...
首页> 外文期刊>Journal of Korean medical science. >The Within-Group Discrimination Ability of the Cancer of the Prostate Risk Assessment Score for Men with Intermediate-Risk Prostate Cancer
【24h】

The Within-Group Discrimination Ability of the Cancer of the Prostate Risk Assessment Score for Men with Intermediate-Risk Prostate Cancer

机译:男性中度前列腺癌的前列腺癌风险评估评分的癌症组内识别能力

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Significant clinical heterogeneity within contemporary risk group is well known, particularly for those with intermediate-risk prostate cancer (IRPCa). Our study aimed to analyze the ability of the Cancer of the Prostate Risk Assessment (CAPRA) score to discern between favorable and non-favorable risk in patients with IRPCa. Methods We retrospectively reviewed the data of 203 IRPCa patients who underwent extraperitoneal robot-assisted radical prostatectomy (RARP) performed by a single surgeon. Pathologic favorable IRPCa was defined as a Gleason score ≤ 6 and organ-confined stage at surgical pathology. The CAPRA score was compared with two established criteria for the within-group discrimination ability. Results Overall, 38 patients (18.7% of the IRPCa cohort) had favorable pathologic features after RARP. The CAPRA score significantly correlated with established criteria I and II and was inversely associated with favorable pathology (all P Conclusion The within-group discrimination ability of preoperative CAPRA score might help in patient counseling and selecting optimal treatments for those with IRPCa. Go to: Graphical Abstract
机译:背景技术众所周知,当代风险人群中存在显着的临床异质性,尤其是对于那些患有中危前列腺癌(IRPCa)的人群。我们的研究旨在分析前列腺癌风险评估(CAPRA)评分在IRPCa患者中区分有利风险和不利风险的能力。方法我们回顾性回顾了由单名外科医生进行的203例腹膜外机器人辅助根治性前列腺切除术(RARP)的IRPCa患者的数据。病理学上有利的IRPCa定义为手术病理学上的Gleason评分≤6和器官受限阶段。将CAPRA得分与组内歧视能力的两个既定标准进行比较。结果总体而言,有38例患者(占IRPCa队列的18.7%)在RARP后具有良好的病理特征。 CAPRA评分与既定标准I和II显着相关,并且与有利的病理学呈负相关(所有P结论术前CAPRA评分的组内歧视能力可能有助于为IRPCa的患者提供咨询和选择最佳治疗方法。抽象

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号